Skip to main content
Log in

Reduced concentration of myocardial Na+,K+-ATPase in human aortic valve disease as well as of Na+,K+- and Ca2+-ATPase in rodents with hypertrophy

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Myocardial Na+,K+-ATPase was studied in patients with aortic valve disease, and myocardial Na+,K+- and Ca2+-ATPase were assessed in spontaneously hypertensive rats (SHR) and hereditary cardiomyopathic hamsters using methods ensuring high enzyme recovery. Na+,K+-ATPase was quantified by [3H]ouabain binding to intact myocardial biopsies from patients with aortic valve disease. Aortic stenosis, regurgitation and a combination hereof were compared with normal human heart and were associated with reductions of left ventricular [3H]ouabain binding site concentration (pmol/g wet weight) of 56, 46 and 60%, respectively (p < 0.01). Na+,K+ and Ca2+-ATPases were quantified by K+- and Ca2+-dependent p-nitrophenyl phosphatase (pNPPase) activity determinations in crude myocardial homogenates from SHR and hereditary cardiomyopathic hamsters. When SHR were compared to age-matched Wistar Kyoto (WKY) rats an increase in heart-body weight ratio of 75% (p < 0.001) was associated with reductions of K+- and Ca2+-dependent pNPPase activities (μmol/min/g wet weight) of 42 (p < 0.01) and 27% (p < 0.05), respectively. When hereditary cardiomyopathic hamsters were compared to age-matched Syrian hamsters an increase in heart-body weight ratio of 69% (p < 0.001) was found to be associated with reductions in K+- and Ca2+-dependent pNPPase activities of 50 (p < 0.001) and 26% (p = 0.05), respectively. The reductions in Na+,K+- and Ca2+-ATPases were selective in relation to overall protein content and were not merely the outcome of increased myocardial mass relative to Na+,K+- and Ca2+-pumps. In conclusion, myocardial hypertrophy is in patients associated with reduced Na+,K+-ATPase concentration and in rodents with reduced Na+,K+- and Ca2+-ATPase concentrations. This may be of importance for development of heart f in hypertrophic heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chambers J: Left ventricular hypertrophy. Br Med J 311: 273, 1995

    Google Scholar 

  2. Skou JC: Enzymatic basis for active transport of Na+ and K+ across cell membrane. Physiol Rev 45: 596–617, 1965

    PubMed  Google Scholar 

  3. Philipson KD: The Cardiac Na+,Ca2+-exchanger In: GA Langer (ed). Calcium and the Heart. Raven Press, New York, 1990, pp 85–108

    Google Scholar 

  4. Carafoli E: Intracellular calcium homeostasis. Ann Rev Physiol 56: 395–433, 1987

    Google Scholar 

  5. Hansen O, Clausen T: Studies on sarcolemma components may be misleading due to inadequat recovery. FEBS 384: 203, 1996

    Google Scholar 

  6. Nørgaard A, Bagger JP, Bjerregaard P, Baandrup U, Kjeldsen K, Thomsen PE: Relation of left ventricular function and Na+,K+-pump concentration in suspected idiopathic dilated cardiomyopathy. Am J Cardiol 61: 1312–1315, 1988

    PubMed  Google Scholar 

  7. Schmidt TA, Svendsen JH, Haunsø S, Kjeldsen K: Quantification of the total Na+,K+-ATPase concentration in atria and ventricles from mammalian species by measuring [ 3 H]ouabain binding to intact sam-ples. Stability to short term ischemia reperfusion. Basic Res Cardiol 85: 411–427, 1990

    PubMed  Google Scholar 

  8. Larsen JS, Kjeldsen K: Quantification in crude homogenates of rat myocardial Na+,K+-and Ca2+-ATPase by K+-and Ca2+-dependent pNPPase. Age dependent changes. Basic Res Cardiol 90: 323–331, 1995

    PubMed  Google Scholar 

  9. Panagia V, Singh JN, Anand Srivastava MB, Pierce GN, Jasmin G, Dhalla NS: Sarcolemmal alterations during the development of genetically determined cardiomyopathy. Cardiovasc Res 18: 567–572, 1984

    PubMed  Google Scholar 

  10. Sulakhe PV, Dhalla NS: Alterations in the activity of cardiac Na+,K+-stimulated ATPase in congestive heart failure. Exp Mol Pathol 18: 100–111, 1973.

    PubMed  Google Scholar 

  11. Nørgaard A, Baandrup U, Larsen JS, Kjeldsen K: Heart Na+, K+-ATPase activity in cardiomyopathic hamsters as estimated from K+-dependent 3-O-MFPase activity in crude homogenates. J Mol Cell Cardiol 19: 589–594, 1987

    PubMed  Google Scholar 

  12. Yazaki Y, Fujii J: Depressed Na+,K+-ATPase activity in the failing rabbit heart. Jpn Heart J 13: 73–83, 1972

    PubMed  Google Scholar 

  13. Prasad K, Khatter JC, Bharadwaj B: Intra-and extracellular electrolytes and sarcolemmal ATPase in the failing heart due to pressure overload in dogs. Cardiovasc Res 13: 95–104, 1979

    PubMed  Google Scholar 

  14. Kjeldsen K, Bjerregaard P, Richter EA, Thomsen PE, Nørgaard, A: Na+,K+-ATPase concentration in rodent and human heart and skeletal muscle: apparent relation to muscle performance. Cardiovasc Res 22: 95–100, 1988

    PubMed  Google Scholar 

  15. Chen CC, Lin Shiau SY: Decreased Na+,K+-ATPase activity and [3H]ouabain binding sites in various tissues of spontaneously hypertensive rats. Eur J Pharmacol 122: 311–319, 1986

    PubMed  Google Scholar 

  16. Sharma RV, Butters CA, Bhalla RC: Alterations in the plasma membrane properties of the myocardium of spontaneously hypertensive rats. Hypertension 8: 583–591,1986

    PubMed  Google Scholar 

  17. Aalkjaer C, Kjeldsen K, Nørgaard A, Clausen T, Mulvany MJ: Ouabain binding and Na+ content in resistance vessels and skeletal muscles of spontaneously hypertensive rats and K+-depleted rats. Hypertension 7: 277–286, 1985

    PubMed  Google Scholar 

  18. Charlemagne D, Orlowski J, Oliviero P, Rannou F, Beuve CS, Swynghedauw B, Lane LK: Alteration of Na+,K+-ATPase subunit mRNA and protein levels in hypertrophied rat heart. J Biol Chem 269: 1541–1547, 1994

    PubMed  Google Scholar 

  19. Magyar CE, Wang J, Azuma KK, McDonough AA: Reciprocal regulation of cardiac Na+, K+-ATPase and Na+/Ca2+-exchanger: hypertension, thyroid hormone, development. Am J Physiol 269: C675–C682, 1995

    PubMed  Google Scholar 

  20. Book CS, Moore RL, Semanchik A, Ng Y: Cardiac hypertrophy alters expression of Na+,K+-ATPase subunit isoforms at mRNA and protein levels in rat myocardium. J Mol Cell Cardiol 26: 591–600, 1994

    PubMed  Google Scholar 

  21. Sweadner KJ, Herrera VLM, Amato S, Moellmann A, Gibbons DK, Repke KRH: Immunologic identification of Na+,K+-ATPase isoforms in myocardium. Circ Res 74: 669–678, 1994

    PubMed  Google Scholar 

  22. Morgan JP: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325: 625–632, 1991

    PubMed  Google Scholar 

  23. de la Bastie D, Levitsky D, Rappaport L, Mercadier JJ, Marotte F, Wisnewsky C, Brovkovich V, Schwartz K, Lompre AM: Function of the sarcoplasmic reticulum and expression of its Ca2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 66: 554–64, 1990

    PubMed  Google Scholar 

  24. O'Brien PJ, Shen H, Weiler J, Mirsalimi M, Julian R: Myocardial Ca 2+-sequestration failure and compensatory increase in Ca 2+-ATPase with congestive cardiomyopathy: kinetic-characterization by a ho-mogenate microassay using real-time ratiometric-indo-1-spectro-fluorometry. Mol Cell Biochem 102: 1–12, 1991

    PubMed  Google Scholar 

  25. Nørgaard A, Kjeldsen, K: Human myocardial Na+,K+-pumps in relation to heart disease. J Appl Cardiol 4: 239–245, 1989

    Google Scholar 

  26. Nørgaard A, Bjerregaard P, Baandrup U, Kjeldsen K, Reske Nielsen E, Thomsen PE: The concentration of the Na+,K+-pump in skeletal and heart muscle in congestive heart failure. Int J Cardiol 26: 185–190, 1990

    PubMed  Google Scholar 

  27. Schmidt TA, Holm-Nielsen P, Kjeldsen K: No upregulation of digitalis glycoside receptor (Na+,K+-ATPase) concentration in human heart left ventricle samples obtained at necropsy after long term digitalisation. Cardiovasc Res 25: 684–691, 1991

    PubMed  Google Scholar 

  28. Schmidt TA, Allen PD, Colucci WS, Marsh JD, Kjeldsen K: No adaption to digitalization as evaluated by digitalis receptor (Na+,K+-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recippients with endstage heart failure. Am J Cardiol 71: 110–114, 1993

    PubMed  Google Scholar 

  29. Schwinger RH, Böhm M, Erdmann E: Effectiveness of cardiac glycosides in human myocardium with and without ‘downregulated’ beta-adrenoceptors. J Cardiovasc Pharmacol 15: 692–697, 1990

    PubMed  Google Scholar 

  30. Schwinger RH, Böhm M, La Rosee K, Schmidt U, Schulz C, Erdmann E: Na+-channel activators increase cardiac glycoside sensitivity in failing human myocardium. J Cardiovasc Pharmacol 19: 554–561, 1992

    PubMed  Google Scholar 

  31. Shamraj Ol, Grupp IL, Grupp G, Melvin D, Gradoux N, Kremers W, Lingrel JB, De Pover, A: Characterisation of Na+,K+-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovas Res 27: 2229–2237, 1993

    Google Scholar 

  32. Ellingsen O, Holthe MR, Svindland A, Aksnes G, Sejersted OM, llebekk A: Na+,K+-pump concentration in hypertrophied human hearts. Eur Heart J 15: 1184–1190, 1994

    PubMed  Google Scholar 

  33. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H: Relation between myo-cardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434–442, 1994

    PubMed  Google Scholar 

  34. Studer R, Reinecke H, Bilger J, Eschenhagen T, Bohm M, Hasenfuss G, Just H, Holtz J, Drexler H: Gene expression of the cardiac Na+, Ca 2+-exchanger in end-stage human heart failure. Circ Res 75: 443–453, 1994

    PubMed  Google Scholar 

  35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951

    PubMed  Google Scholar 

  36. Nørgaard A, Kjeldsen K, Hansen O, Clausen T, Larsen CG, Larsen FG: Quantification of the [3H]ouabain binding site concentration in human myocardium: a postmortem study. Cardiovasc Res 20: 428–435, 1986

    PubMed  Google Scholar 

  37. Skou JC, Esmann M: Preparation of membrane-bound and of solubilized Na+,K+-ATPase from rectal glands of Squalus acanthias. The effect of preparative procedures on purity, specific and molar activity. Biochim Biophys Acta 567: 436–444, 1979

    PubMed  Google Scholar 

  38. Luccchesi PA, Sweadner KJ: Postnatal changes in Na+,K+-ATPase isoform expression in rat cardiac ventricle. J Biol Chem 266: 9327–9331, 1991

    PubMed  Google Scholar 

  39. Dauncey MJ, Burton KA: [ 3 H]ouabain binding sites in porcine skeletal muscle as influenced by environmental temperature and energy intake. Pflugers Arch 414: 317–323, 1989

    PubMed  Google Scholar 

  40. Nørgaard A, Kjeldsen K, Hansen O: K+-dependent 3-O-methylfluorescein phosphatase activity in crude homogenate of rodent heart ventricle: effect of K+-depletion and changes in thyroid status. Eur J Pharmacol 113: 373–382, 1985

    PubMed  Google Scholar 

  41. O'Gorman DJ, Sheridan DJ: Abnormalities of the coronary circulation associated with left ventricular hypertrophy. Clin Sci 81: 703–713, 1991

    PubMed  Google Scholar 

  42. Tsuruya Y, Ikeda U, Yamamoto K, Seino Y, Kanbe T, Shimada K: Decreased Na+, K+-ATPase gene expression in cardiomyopathic hamster hearts. Life Sci 54: 71–77, 1994

    PubMed  Google Scholar 

  43. Jasmin G, Proschek L: Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the OM-X7.1 line. Muscle Nerve 5: 20–25, 1982

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stenfatt Larsen, J., Andersen Schmidt, T., surname, H. et al. Reduced concentration of myocardial Na+,K+-ATPase in human aortic valve disease as well as of Na+,K+- and Ca2+-ATPase in rodents with hypertrophy. Mol Cell Biochem 169, 85–93 (1997). https://doi.org/10.1023/A:1006851411650

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006851411650

Navigation